2023-03-012024-03-312024-03-31false13925206THE QUADRANT LAB LTD2024-11-14iso4217:GBPxbrli:pure139252062023-03-01139252062024-03-31139252062023-03-012024-03-31139252062022-02-18139252062023-02-28139252062022-02-182023-02-2813925206bus:SmallEntities2023-03-012024-03-3113925206bus:AuditExempt-NoAccountantsReport2023-03-012024-03-3113925206bus:FullAccounts2023-03-012024-03-3113925206bus:PrivateLimitedCompanyLtd2023-03-012024-03-3113925206core:WithinOneYear2024-03-3113925206core:AfterOneYear2024-03-3113925206core:WithinOneYear2023-02-2813925206core:AfterOneYear2023-02-2813925206core:ShareCapital2024-03-3113925206core:SharePremium2024-03-3113925206core:RevaluationReserve2024-03-3113925206core:OtherReservesSubtotal2024-03-3113925206core:RetainedEarningsAccumulatedLosses2024-03-3113925206core:ShareCapital2023-02-2813925206core:SharePremium2023-02-2813925206core:RevaluationReserve2023-02-2813925206core:OtherReservesSubtotal2023-02-2813925206core:RetainedEarningsAccumulatedLosses2023-02-2813925206core:LandBuildings2024-03-3113925206core:PlantMachinery2024-03-3113925206core:Vehicles2024-03-3113925206core:FurnitureFittings2024-03-3113925206core:OfficeEquipment2024-03-3113925206core:NetGoodwill2024-03-3113925206core:IntangibleAssetsOtherThanGoodwill2024-03-3113925206core:ListedExchangeTraded2024-03-3113925206core:UnlistedNon-exchangeTraded2024-03-3113925206core:LandBuildings2023-02-2813925206core:PlantMachinery2023-02-2813925206core:Vehicles2023-02-2813925206core:FurnitureFittings2023-02-2813925206core:OfficeEquipment2023-02-2813925206core:NetGoodwill2023-02-2813925206core:IntangibleAssetsOtherThanGoodwill2023-02-2813925206core:ListedExchangeTraded2023-02-2813925206core:UnlistedNon-exchangeTraded2023-02-2813925206core:LandBuildings2023-03-012024-03-3113925206core:PlantMachinery2023-03-012024-03-3113925206core:Vehicles2023-03-012024-03-3113925206core:FurnitureFittings2023-03-012024-03-3113925206core:OfficeEquipment2023-03-012024-03-3113925206core:NetGoodwill2023-03-012024-03-3113925206core:IntangibleAssetsOtherThanGoodwill2023-03-012024-03-3113925206core:ListedExchangeTraded2023-03-012024-03-3113925206core:UnlistedNon-exchangeTraded2023-03-012024-03-3113925206core:MoreThanFiveYears2023-03-012024-03-3113925206core:Non-currentFinancialInstruments2024-03-3113925206core:Non-currentFinancialInstruments2023-02-2813925206dpl:CostSales2023-03-012024-03-3113925206dpl:DistributionCosts2023-03-012024-03-3113925206core:LandBuildings2023-03-012024-03-3113925206core:PlantMachinery2023-03-012024-03-3113925206core:Vehicles2023-03-012024-03-3113925206core:FurnitureFittings2023-03-012024-03-3113925206core:OfficeEquipment2023-03-012024-03-3113925206dpl:AdministrativeExpenses2023-03-012024-03-3113925206core:NetGoodwill2023-03-012024-03-3113925206core:IntangibleAssetsOtherThanGoodwill2023-03-012024-03-3113925206dpl:GroupUndertakings2023-03-012024-03-3113925206dpl:ParticipatingInterests2023-03-012024-03-3113925206dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-03-3113925206core:ListedExchangeTraded2023-03-012024-03-3113925206dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-03-3113925206core:UnlistedNon-exchangeTraded2023-03-012024-03-3113925206dpl:CostSales2022-02-182023-02-2813925206dpl:DistributionCosts2022-02-182023-02-2813925206core:LandBuildings2022-02-182023-02-2813925206core:PlantMachinery2022-02-182023-02-2813925206core:Vehicles2022-02-182023-02-2813925206core:FurnitureFittings2022-02-182023-02-2813925206core:OfficeEquipment2022-02-182023-02-2813925206dpl:AdministrativeExpenses2022-02-182023-02-2813925206core:NetGoodwill2022-02-182023-02-2813925206core:IntangibleAssetsOtherThanGoodwill2022-02-182023-02-2813925206dpl:GroupUndertakings2022-02-182023-02-2813925206dpl:ParticipatingInterests2022-02-182023-02-2813925206dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-182023-02-2813925206core:ListedExchangeTraded2022-02-182023-02-2813925206dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-182023-02-2813925206core:UnlistedNon-exchangeTraded2022-02-182023-02-2813925206core:NetGoodwill2024-03-3113925206core:IntangibleAssetsOtherThanGoodwill2024-03-3113925206core:LandBuildings2024-03-3113925206core:PlantMachinery2024-03-3113925206core:Vehicles2024-03-3113925206core:FurnitureFittings2024-03-3113925206core:OfficeEquipment2024-03-3113925206core:AfterOneYear2024-03-3113925206core:WithinOneYear2024-03-3113925206core:ListedExchangeTraded2024-03-3113925206core:UnlistedNon-exchangeTraded2024-03-3113925206core:ShareCapital2024-03-3113925206core:SharePremium2024-03-3113925206core:RevaluationReserve2024-03-3113925206core:OtherReservesSubtotal2024-03-3113925206core:RetainedEarningsAccumulatedLosses2024-03-3113925206core:NetGoodwill2023-02-2813925206core:IntangibleAssetsOtherThanGoodwill2023-02-2813925206core:LandBuildings2023-02-2813925206core:PlantMachinery2023-02-2813925206core:Vehicles2023-02-2813925206core:FurnitureFittings2023-02-2813925206core:OfficeEquipment2023-02-2813925206core:AfterOneYear2023-02-2813925206core:WithinOneYear2023-02-2813925206core:ListedExchangeTraded2023-02-2813925206core:UnlistedNon-exchangeTraded2023-02-2813925206core:ShareCapital2023-02-2813925206core:SharePremium2023-02-2813925206core:RevaluationReserve2023-02-2813925206core:OtherReservesSubtotal2023-02-2813925206core:RetainedEarningsAccumulatedLosses2023-02-2813925206core:NetGoodwill2022-02-1813925206core:IntangibleAssetsOtherThanGoodwill2022-02-1813925206core:LandBuildings2022-02-1813925206core:PlantMachinery2022-02-1813925206core:Vehicles2022-02-1813925206core:FurnitureFittings2022-02-1813925206core:OfficeEquipment2022-02-1813925206core:AfterOneYear2022-02-1813925206core:WithinOneYear2022-02-1813925206core:ListedExchangeTraded2022-02-1813925206core:UnlistedNon-exchangeTraded2022-02-1813925206core:ShareCapital2022-02-1813925206core:SharePremium2022-02-1813925206core:RevaluationReserve2022-02-1813925206core:OtherReservesSubtotal2022-02-1813925206core:RetainedEarningsAccumulatedLosses2022-02-1813925206core:AfterOneYear2023-03-012024-03-3113925206core:WithinOneYear2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-03-3113925206core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113925206core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113925206core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2813925206core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2813925206core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2813925206core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2813925206core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2813925206core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2813925206core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2813925206core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2813925206core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2813925206bus:Director12023-03-012024-03-3113925206bus:Director22023-03-012024-03-3113925206bus:Director32023-03-012024-03-31

THE QUADRANT LAB LTD

Registered Number
13925206
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2024

THE QUADRANT LAB LTD
Company Information
for the period from 1 March 2023 to 31 March 2024

Directors

JUNEJA, Manpreet Kaur
JUNEJA, Rajvansh
JUNEJA, Simranjeet

Company Secretary

JUNEJA, Simranjeet

Registered Address

71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

Registered Number

13925206 (England and Wales)
THE QUADRANT LAB LTD
Balance Sheet as at
31 March 2024

Notes

31 Mar 2024

28 Feb 2023

£

£

£

£

Current assets
Debtors14,250-
Cash at bank and on hand5581,251
14,8081,251
Creditors amounts falling due within one year3(8,170)(3,200)
Net current assets (liabilities)6,638(1,949)
Total assets less current liabilities6,638(1,949)
Net assets6,638(1,949)
Capital and reserves
Called up share capital100100
Profit and loss account6,538(2,049)
Shareholders' funds6,638(1,949)
The financial statements were approved and authorised for issue by the Board of Directors on 14 November 2024, and are signed on its behalf by:
JUNEJA, Manpreet Kaur
Director
JUNEJA, Rajvansh
Director
JUNEJA, Simranjeet
Director

Registered Company No. 13925206
THE QUADRANT LAB LTD
Notes to the Financial Statements
for the period ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year00
3.Creditors: amounts due within one year

2024

2023

££
Bank borrowings and overdrafts8,1703,200
Total8,1703,200